UA41401C2 - Фармацевтичний контрацептивний комбінований препарат - Google Patents

Фармацевтичний контрацептивний комбінований препарат

Info

Publication number
UA41401C2
UA41401C2 UA96104081A UA96104081A UA41401C2 UA 41401 C2 UA41401 C2 UA 41401C2 UA 96104081 A UA96104081 A UA 96104081A UA 96104081 A UA96104081 A UA 96104081A UA 41401 C2 UA41401 C2 UA 41401C2
Authority
UA
Ukraine
Prior art keywords
estrogen
daily dosage
hormonal
dosage units
component
Prior art date
Application number
UA96104081A
Other languages
English (en)
Russian (ru)
Inventor
Урсула ЛАХНІТ
Урсула Лахнит
Берндт ДЮСТЕРБЕРГ
Юрген ШПОНА
Original Assignee
Шерінг Актієнгезеллшафт
Шеринг Актиенгезеллшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6514578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA41401(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Шерінг Актієнгезеллшафт, Шеринг Актиенгезеллшафт filed Critical Шерінг Актієнгезеллшафт
Publication of UA41401C2 publication Critical patent/UA41401C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Фармацевтичний контрацептивний комбінований препарат складається з двох упакованих в просторовому відношенні роздільно в одній пакувальній одиниці, призначених для перорального застосування за часом послідовно гормональних компонентів, які складаються, зважаючи на обставини, з певного числа поміщених в просторовому відношенні роздільно в одну пакувальну одиницю та вилучуваних окремо добових одиниць дозувань. Перший з гормональних компонентів як гормонально біологічно активну речовину містить в комбінації естрогенний і, щонайменше, в достатньому для пригнічення овуляції дозуванні гестагенний препарат в однофазовому або в багатофазовому виконанні. Другий гормональний компонент як гормонально біологічно активну речовину містить лише один естрогенний препарат. При цьому перший гормональний компонент охоплює 24, а другий гормональний компонент охоплює 4-10 добових одиниць дозувань. Добові одиниці дозувань першого гормонального компоненту не містять комбінації біогенного естрогену і синтетичного естрогену, причому загальне число добових одиниць дозувань гормонів дорівнює загальній кількості днів бажаного циклу.
UA96104081A 1994-03-30 1995-03-30 Фармацевтичний контрацептивний комбінований препарат UA41401C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4411585A DE4411585A1 (de) 1994-03-30 1994-03-30 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
PCT/EP1995/001190 WO1995026730A1 (de) 1994-03-30 1995-03-30 Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption

Publications (1)

Publication Number Publication Date
UA41401C2 true UA41401C2 (uk) 2001-09-17

Family

ID=6514578

Family Applications (1)

Application Number Title Priority Date Filing Date
UA96104081A UA41401C2 (uk) 1994-03-30 1995-03-30 Фармацевтичний контрацептивний комбінований препарат

Country Status (25)

Country Link
US (1) US5756490A (uk)
EP (1) EP0750501B1 (uk)
JP (1) JPH09511243A (uk)
KR (1) KR100352571B1 (uk)
CN (1) CN1108800C (uk)
AT (1) ATE222494T1 (uk)
AU (1) AU2073595A (uk)
BG (1) BG63192B1 (uk)
BR (1) BR9507251A (uk)
CA (1) CA2186739A1 (uk)
CZ (1) CZ291698B6 (uk)
DE (2) DE4411585A1 (uk)
DK (1) DK0750501T3 (uk)
ES (1) ES2181770T3 (uk)
FI (1) FI963831A (uk)
HU (1) HUT75521A (uk)
NO (1) NO964089L (uk)
NZ (1) NZ282824A (uk)
PL (1) PL316569A1 (uk)
PT (1) PT750501E (uk)
RO (1) RO118375B1 (uk)
RU (1) RU2165258C2 (uk)
SK (1) SK124396A3 (uk)
UA (1) UA41401C2 (uk)
WO (1) WO1995026730A1 (uk)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
EP0792152B1 (en) * 1994-11-22 2004-04-14 Balance Pharmaceuticals, Inc. Methods of contraception
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
AU726283B2 (en) * 1995-06-28 2000-11-02 Schering Aktiengesellschaft Pharmaceutical combined preparations, kit and method for hormonal contraception
AU2815897A (en) * 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
BR9710566A (pt) * 1996-07-26 1999-08-17 American Home Prod M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
BR9710565A (pt) * 1996-07-26 1999-08-17 American Home Prod Contraceptivo oral
WO1998004267A1 (en) * 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
RU2269342C2 (ru) * 1999-08-31 2006-02-10 Шеринг Акциенгезелльшафт Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
DE122009000007I2 (de) * 1999-08-31 2011-07-21 Bayer Schering Pharma Pharmazeutische kombination von ethinylestradiol und drospirenone als empfangnisverhutendes mittel.
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
PT1453521E (pt) * 2001-12-05 2013-10-08 Teva Womens Health Inc Contracetivos orais para prevenir a gravidez e diminuir a sintomatologia pré-menstrual
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
CN1863537A (zh) * 2003-10-01 2006-11-15 詹森药业有限公司 延长的三阶段避孕法
EP1535618A1 (en) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
US20050113350A1 (en) * 2003-11-26 2005-05-26 Bernd Duesterberg Extended use combination comprising estrogens and progestins
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US7704984B2 (en) 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
MX2008011074A (es) * 2006-03-02 2008-09-10 Warner Chilcott Co Inc Metodo anticonceptivo oral multifasico de ciclo prolongado.
US11376263B2 (en) 2020-10-08 2022-07-05 Fortress Biotech, Inc. Cyproterone acetate compositions and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (uk) * 1966-11-02 1968-05-03
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (uk) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
MX9604440A (es) 1997-07-31
DK0750501T3 (da) 2002-12-23
NZ282824A (en) 1998-07-28
CZ287996A3 (en) 1997-02-12
AU2073595A (en) 1995-10-23
RO118375B1 (ro) 2003-05-30
HU9602657D0 (en) 1996-11-28
DE4411585A1 (de) 1995-10-05
FI963831A (fi) 1996-11-29
ES2181770T3 (es) 2003-03-01
NO964089L (no) 1996-11-07
US5756490A (en) 1998-05-26
DE59510333D1 (de) 2002-09-26
NO964089D0 (no) 1996-09-27
SK124396A3 (en) 1997-05-07
FI963831A0 (fi) 1996-09-25
HUT75521A (en) 1997-05-28
BG100940A (en) 1998-03-31
EP0750501A1 (de) 1997-01-02
BR9507251A (pt) 1997-09-02
ATE222494T1 (de) 2002-09-15
RU2165258C2 (ru) 2001-04-20
JPH09511243A (ja) 1997-11-11
PT750501E (pt) 2003-01-31
BG63192B1 (bg) 2001-06-29
PL316569A1 (en) 1997-01-20
WO1995026730A1 (de) 1995-10-12
CA2186739A1 (en) 1995-10-12
EP0750501B1 (de) 2002-08-21
KR100352571B1 (ko) 2003-01-06
CN1108800C (zh) 2003-05-21
CN1159161A (zh) 1997-09-10
CZ291698B6 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
ATE136781T1 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
NL300381I2 (nl) Estradiolvaleraat en dienogest
HU0301171D0 (en) Antifungal active ingredients, pharmaceutical compositions containing the same and process for their preparation
NZ298769A (en) use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception
ZA964873B (en) Tricot-like pouch for the delivery of topical drugs and cosmetics.
RU96119957A (ru) Фармацевтический комбинированный препарат для гормональной контрацепции
HK1019305A1 (en) Progestogen-anti-progestogen regimens
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
WO1994002103A3 (de) Ovulationshemmendes mittel zur hormonalen kontrazeption
HUP9900612A3 (en) Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
UA81387C2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
ZA975160B (en) Transdermic systems containing 2 active ingredients in separate compartments, their preparation process and their use as medicaments.
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
UA41351C2 (uk) Спосіб контрацепції та набір таблеток
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
MX9707009A (es) Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas.
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
RU96102023A (ru) Гормональное средство для лечения угрей